In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.
Acosta Felquer, M. L., Coates, L. C., Soriano, E. R., Ranza, R., Espinoza, L. R., Helliwell, P. S., FitzGerald, O., McHugh, N., Roussou, E., & Mease, P. J. (2014). Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review. The Journal of Rheumatology, 41(11), 2277-2285. https://doi.org/10.3899/jrheum.140876